AstraZeneca medications

The list below contains full Prescribing Information for all of our medicines, and a range of websites dedicated to providing you with product-specific information. The information contained below is intended for US residents only. 

In order to monitor the safety of AstraZeneca products, we encourage reporting any side effects experienced while taking an AstraZeneca product to the AZ Information Center at 1-800-236-9933. Alternatively, you can report any side effects of prescription drugs directly to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

Help affording your medicines

We believe it’s not enough for us to simply make medicines. We have to make sure that the people who need those medicines can get them.

Learn more

 


ANDEXXA® Coagulation Factor Xa (recombinant), inactivated-zhzo

Prescribing Information
Consumer site
Health care professional site

 

BEVESPI AEROSPHERE® (glycopyrrolate and formoterol fumarate) Inhalation Aerosol

Prescribing Information
Consumer site
Health care professional site

 

BREZTRI AEROSPHERE® (budesonide, glycopyrrolate and formoterol fumarate) Inhalation Aerosol

Prescribing Information
Consumer site
Health care professional site

 

BRILINTA® (ticagrelor) tablets

Prescribing Information including Boxed WARNINGS
Consumer site
Health care professional site

 

BYDUREON® (exenatide extended-release) injectable suspension

Prescribing Information including Boxed WARNING
Consumer site
Health care professional site

 

BYDUREON BCise® (exenatide extended-release) injectable suspension

Prescribing information including Boxed WARNING
Consumer site
Health care professional site

 

BYETTA® (exenatide) injection

Prescribing Information
Consumer site
Health care professional site

 

CALQUENCE® (acalabrutinib) capsules

Prescribing information
Consumer site
Health care professional site

 

CRESTOR® (rosuvastatin calcium) Tablets

Prescribing Information
Consumer site
Health care professional site

 

DALIRESP® (roflumilast) tablets

Prescribing Information
Consumer site
Health care professional site

 

ENHERTU® (fam-trastuzumab deruxtecan-nxki) injection for intravenous use

Prescribing Information including Boxed WARNING
Health care professional site
 

EPANOVA® (omega-3-carboxylic acids) Capsules

Prescribing Information

 

EVUSHELD™ (tixagevimab co-packaged with cilgavimab) Pre-exposure prophylaxis of COVID-19 for emergency use only 

Fact Sheet for Healthcare Providers English/Español
Fact Sheet for Patients, Parents and Caregivers English/Español
FDA Letter of Authorization
Consumer site
Health care professional site

 

FARXIGA® (dapagliflozin) tablets

Prescribing Information
Consumer site
Health care professional site

 

FASENRA® (benralizumab) injection, for subcutaneous use

Prescribing Information
Consumer site
Health care professional site

 

FASLODEX® (fulvestrant) injection, for intramuscular use

Prescribing Information
Consumer site
Health care professional site

 

FLUMIST® QUADRIVALENT (Influenza Vaccine Live, Intranasal)

Prescribing Information
Consumer site
Health care professional site

 

IMFINZI® (durvalumab) injection, for intravenous use

Prescribing Information 
Consumer website
Health care professional website

 

IRESSA® (gefitinib)

Prescribing Information
Consumer site

KOMBIGLYZE® XR (saxagliptin and metformin HCl extended-release) tablets

Prescribing Information including Boxed WARNING
Consumer site
Health care professional site

 

LOKELMA® (sodium zirconium cyclosilicate) 10 g for oral suspension

Prescribing Information
Health care professional site

 

LUMOXITI® (moxetumomab pasudotox-tdfk) for injection, for intravenous use

Prescribing Information including Boxed WARNING
Consumer site
Health care professional site

 

LYNPARZA® (olaparib) tablets

Prescribing Information
Consumer site
Health care professional site

 

NEXIUM® (esomeprazole magnesium) delayed-release capsules, for oral suspension

Prescribing Information
Consumer site
Health care professional site

 

NEXIUM® (esomeprazole magnesium) for delayed-release oral suspension

Prescribing Information
Consumer site
Health care professional site

 

NEXIUM® I.V. (esomeprazole sodium) for injection, for intravenous use

Prescribing Information

 

ONGLYZA® (saxagliptin) tablets

Prescribing Information
Consumer site
Health care professional site

 

PULMICORT FLEXHALER® (budesonide inhalation powder)

Prescribing Information
Consumer site
Health care professional site

 

PULMICORT RESPULES® (budesonide inhalation suspension)

Prescribing Information
Consumer site

 

QTERN® (dapagliflozin and saxagliptin) tablets

Prescribing Information

 

SAPHNELO™ (anifrolumab-fnia) Injection, for intravenous use

Prescribing Information
Consumer site
Health care professional site

 

SEROQUEL® (quetiapine) tablets

Prescribing Information including Boxed WARNINGS

 

SEROQUEL XR® (quetiapine) Extended-release tablets

Prescribing Information including Boxed WARNINGS
Consumer site
Health care professional site

 

SYMBICORT® (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol

Prescribing Information
Consumer site
Health care professional site

 

SYMLIN® (pramlintide acetate) injection

Prescribing Information including Boxed WARNING
Consumer site
Health care professional site

 

TAGRISSO® (osimertinib) tablets

Prescribing Information
Consumer site
Health care professional site

 

TEZSPIRE™ (tezepelumab-ekko) Injection, for subcutaneous use

Prescribing Information
Consumer site
Health care professional site

 

XIGDUO® XR (dapagliflozin and metformin hydrochloride extended-release) tablets

Prescribing Information including Boxed WARNING



Veeva ID: US-62564
Date of Preparation: April 2022